Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for Pain in Symptomatic Knee Osteoarthritis
NCT04607603Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2020
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in knee osteoarthritis (OA) comparing Cannabidiol with Placebo (2 arms). Primary endpoint: Western Ontario and McMasters Universities Osteoarthritis Index Pain Score at 8 weeks. Started Oct 2020; status: completed.
02
Drugs
cannabidiol
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04607603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04607603.